These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 7799398)

  • 1. The discovery of novel, structurally diverse protein kinase C agonists through computer 3D-database pharmacophore search. Molecular modeling studies.
    Wang S; Zaharevitz DW; Sharma R; Marquez VE; Lewin NE; Du L; Blumberg PM; Milne GW
    J Med Chem; 1994 Dec; 37(26):4479-89. PubMed ID: 7799398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conformationally constrained analogues of diacylglycerol (DAG). 16. How much structural complexity is necessary for recognition and high binding affinity to protein kinase C?
    Nacro K; Bienfait B; Lee J; Han KC; Kang JH; Benzaria S; Lewin NE; Bhattacharyya DK; Blumberg PM; Marquez VE
    J Med Chem; 2000 Mar; 43(5):921-44. PubMed ID: 10715158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conformationally constrained analogues of diacylglycerol. 11. Ultrapotent protein kinase C ligands based on a chiral 5-disubstituted tetrahydro-2-furanone template.
    Lee J; Wang S; Milne GW; Sharma R; Lewin NE; Blumberg PM; Marquez VE
    J Med Chem; 1996 Jan; 39(1):29-35. PubMed ID: 8568819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein kinase C ligands based on tetrahydrofuran templates containing a new set of phorbol ester pharmacophores.
    Lee J; Kang JH; Lee SY; Han KC; Torres CM; Bhattacharyya DK; Blumberg PM; Marquez VE
    J Med Chem; 1999 Oct; 42(20):4129-39. PubMed ID: 10514283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conformationally constrained analogues of diacylglycerol (DAG). 23. Hydrophobic ligand-protein interactions versus ligand-lipid interactions of DAG-lactones with protein kinase C (PK-C).
    Tamamura H; Sigano DM; Lewin NE; Peach ML; Nicklaus MC; Blumberg PM; Marquez VE
    J Med Chem; 2004 Sep; 47(20):4858-64. PubMed ID: 15369389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rational design, synthesis, pharmacophore modeling, and docking studies for identification of novel potent DNA-PK inhibitors.
    Ihmaid S; Ahmed HEA; Al-Sheikh Ali A; Sherif YE; Tarazi HM; Riyadh SM; Zayed MF; Abulkhair HS; Rateb HS
    Bioorg Chem; 2017 Jun; 72():234-247. PubMed ID: 28482264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CoMFA-based prediction of agonist affinities at recombinant D1 vs D2 dopamine receptors.
    Wilcox RE; Tseng T; Brusniak MY; Ginsburg B; Pearlman RS; Teeter M; DuRand C; Starr S; Neve KA
    J Med Chem; 1998 Oct; 41(22):4385-99. PubMed ID: 9784114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthetic diacylglycerols (DAG) and DAG-lactones as activators of protein kinase C (PK-C).
    Marquez VE; Blumberg PM
    Acc Chem Res; 2003 Jun; 36(6):434-43. PubMed ID: 12809530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conformationally constrained analogues of diacylglycerol. 12. Ultrapotent protein kinase C ligands based on a chiral 4,4-disubstituted heptono-1,4-lactone template.
    Lee J; Sharma R; Wang S; Milne GW; Lewin NE; Szallasi Z; Blumberg PM; George C; Marquez VE
    J Med Chem; 1996 Jan; 39(1):36-45. PubMed ID: 8568825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular modeling and site-directed mutagenesis studies of a phorbol ester-binding site in protein kinase C.
    Wang S; Kazanietz MG; Blumberg PM; Marquez VE; Milne GW
    J Med Chem; 1996 Jun; 39(13):2541-53. PubMed ID: 8691452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conformationally constrained analogues of diacylglycerol. 10. Ultrapotent protein kinase C ligands based on a racemic 5-disubstituted tetrahydro-2-furanone template.
    Sharma R; Lee J; Wang S; Milne GW; Lewin NE; Blumberg PM; Marquez VE
    J Med Chem; 1996 Jan; 39(1):19-28. PubMed ID: 8568806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the phorbol ester pharmacophore on protein kinase C as a guide to the rational design of new classes of analogs.
    Wender PA; Koehler KF; Sharkey NA; Dell'Aquila ML; Blumberg PM
    Proc Natl Acad Sci U S A; 1986 Jun; 83(12):4214-8. PubMed ID: 3086877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of HIV-1 integrase inhibitors by pharmacophore searching.
    Hong H; Neamati N; Wang S; Nicklaus MC; Mazumder A; Zhao H; Burke TR; Pommier Y; Milne GW
    J Med Chem; 1997 Mar; 40(6):930-6. PubMed ID: 9083481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of a pharmacophore model for identification of novel ligands for the benzodiazepine binding site of the GABAA receptor.
    Kahnberg P; Howard MH; Liljefors T; Nielsen M; Nielsen EØ; Sterner O; Pettersson I
    J Mol Graph Model; 2004 Dec; 23(3):253-61. PubMed ID: 15530821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of high-affinity ligands of sigma1 receptor, ERG2, and emopamil binding protein by pharmacophore modeling and virtual screening.
    Laggner C; Schieferer C; Fiechtner B; Poles G; Hoffmann RD; Glossmann H; Langer T; Moebius FF
    J Med Chem; 2005 Jul; 48(15):4754-64. PubMed ID: 16033255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modeling of the bryostatins to the phorbol ester pharmacophore on protein kinase C.
    Wender PA; Cribbs CM; Koehler KF; Sharkey NA; Herald CL; Kamano Y; Pettit GR; Blumberg PM
    Proc Natl Acad Sci U S A; 1988 Oct; 85(19):7197-201. PubMed ID: 3174627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-1 integrase pharmacophore: discovery of inhibitors through three-dimensional database searching.
    Nicklaus MC; Neamati N; Hong H; Mazumder A; Sunder S; Chen J; Milne GW; Pommier Y
    J Med Chem; 1997 Mar; 40(6):920-9. PubMed ID: 9083480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study on selectin blocker. 8. Lead discovery of a non-sugar antagonist using a 3D-pharmacophore model.
    Hiramatsu Y; Tsukida T; Nakai Y; Inoue Y; Kondo H
    J Med Chem; 2000 Apr; 43(8):1476-83. PubMed ID: 10780903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ligand-Based Pharmacophore Modeling Using Novel 3D Pharmacophore Signatures.
    Kutlushina A; Khakimova A; Madzhidov T; Polishchuk P
    Molecules; 2018 Nov; 23(12):. PubMed ID: 30486389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure/activity relationships of polyfunctional diterpenes of the tigliane type. A pharmacophore model for protein-kinase-C activators based on structure/activity studies and molecular modeling of the tumor promoters 12-O-tetradecanoylphorbol 13-acetate and 3-O-tetradecanoylingenol.
    Krauter G; Von der Lieth CW; Schmidt R; Hecker E
    Eur J Biochem; 1996 Dec; 242(2):417-27. PubMed ID: 8973661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.